###### Strengths and limitations of this study

-   This study described the current status of the hypertension in nurses according to the 2010 Chinese guideline and the 2017 American College of Cardiology/American Heart Association guideline.

-   This study had a large sample size, covering 13 regions, and described the prevalence and distribution of hypertension in different population groups.

-   Not all the relationships between hypertension and specific factors identified in this study were investigated.

Introduction {#s1}
============

With the rapid development of society and economy, changes in lifestyle and the ageing of the population, hypertension has become one of the most important public health issues in the world. Its complications are associated with high morbidity and mortality, as well as high rate of consumption of medical resources.[@R1] The direct economic burden caused by hypertension in China in 2013 amounted to 210.3 billion yuan, accounting for 6.61% of the total expenditure on health in China.^[@R2]^ According to the China Health and Nutrition Survey (CHNS) data from 1991 to 2011, the adjusted prevalence rate of hypertension in Chinese over 18 years old increased from 15.6% to 20.9%, and the prevalence rate of hypertension increased[@R5]; however, the awareness, treatment and control rates were still low.[@R6]

The 2017 American Heart Association (AHA)/American College of Cardiology (ACC) guideline for the prevention, detection, evaluation and management of high blood pressure (BP) in adults has been recently released. A significant transformation in the guideline is the shift in the definition of hypertension, from a systolic blood pressure (SBP) of ≥140 mm Hg or a diastolic blood pressure (DBP) of ≥90 mm Hg to an SBP of ≥130 mm Hg or a DBP of ≥80 mm Hg. According to the 2017 AHA/ACC guideline, the prevalence rate of hypertension increased from 31.9% to 45.6% in the USA.[@R7]

The 2017 ACC/AHA guideline may bring critical effects on the hypertension status in different regions worldwide.[@R8] Recently, more and more researchers focused on the issues about the potential impacts of the updated guideline on the Chinese population. A nationally representative cross-sectional study examined the hypertension prevalence rate according to the new guideline and found an absolute increase of 17.0% among adults aged 45--75 years in China.^[@R12]^ Additionally, a survey examined the effects of the new guideline in Southwest China and found that the prevalence of hypertension was nearly twice than that in the Chinese hypertension guideline.^[@R13]^ Findings from previous studies were mainly focused on the increase in the prevalence of hypertension in the Chinese general population under the new guideline, but it was still largely unclear how the new guideline exerted influence on the hypertension status in different social communities in China. Moreover, the BP levels of nursing staff, a special class of professional group whose work was of high intensity, characterised by high stress level and requiring frequent rotating shifts, should be paid more attention to.[@R14] This study is a cross-sectional survey based on a large number of nursing staffs. The purpose was to analyse the alteration of prevalence, awareness, treatment and control rates of hypertension in Chinese nursing staff based on the 2017 ACC/AHA guideline and the 2010 Chinese guideline, as well as the characteristics of the newly diagnosed hypertension population.

Methods {#s2}
=======

Participants and data collection {#s2-1}
--------------------------------

This cross-sectional study was conducted from October 2016 to February 2017 using a general survey design. Candidates of registered nurses from 512 medical institutions in 13 cities in Hebei Province (N=143 772) were invited to participate in the survey, and few of them who refused to participate were excluded from the research group. Based on who accepted the survey and submitted questionnaires online, we collected 93 603 incumbent nurses aged 18--65 years. Undoubtedly, a response rate of 65.11% was achieved. After excluding 788 individuals with incomplete information in the questionnaires, 92 815 participants were included in the final analysis.

Electronic folders were distributed to the Nursing Quality Control Center (NQCC) of each city through the NQCC of Hebei Province. The folder contained three documents: the link to the electronic questionnaire (SO JUMP), a document on BP measurement precautions and an investigation notice. On receiving the folder, the contact person of each NQCC sent it to the nursing department of all medical institutions in the different cities. Then, the nursing department sent it to the head managers of the departments, who organised the nurses to fill in the questionnaire online. A researcher was arranged to report the response rate to the NQCC of each city every day. The questionnaire content mainly involved (1) the demographic characteristic: hospital name, hospital grade, department, name, age, gender, height and weight; (2) the SBP and the DBP; and (3) the risk factors associated with hypertension: monthly night shift frequency, years of hyperlipidaemia, years of diabetes, years of hypertension, educational status, marital status, menstruation condition, reproductive history, history of abortion, whether the participant received hormone replacement therapy, smoking habit, alcohol drinking, physical exercise and family history of hypertension.[@R16]

Participants and public involvement {#s2-2}
-----------------------------------

In this study, self-report was adopted, and all the participants were nurses who understood the effect of BP measurement by themselves. After receiving the notification on the BP survey, all participants filled in and submitted relevant data online, and those who did not accept could refuse to participate. Although the participants or the public were not formally involved in the design and conduct of the study, the questionnaire used for data collection and the specific assessment conduction were developed based on previous experiences in other surveys and expert opinions. The research data was sent to the Municipal Nursing Quality and Control Centre in Hebei Province.

Measurement {#s2-3}
-----------

### BP measurement and data reporting {#s2-3-1}

The nursing staff measured BP by themselves and reported data through the network. Although nurses mastered the BP measurement method generally, the researchers standardised the method of BP measurement and gave relevant attention in order to reduce measurement bias as much as possible. In order to ensure the accuracy of the report and BP data, a series of measures were adopted for quality control. First, our research group established a three-level supervision mechanism that contained the NQCC, nursing departments and head nurses of hospitals at all levels. Each day during the investigations, research group members exported data from the information platform to conduct data analysis, calculated the number of staff who had finished the questionnaire in each hospital, then fed it back it to their municipal quality control centres for controlling researching progress. Additionally, each questionnaire was checked and verified by professional quality investigators. After that, the results of verified data were sent to the municipal quality control centres for complementing the missing items and correcting mistakes. What is more, we also attached important cautions while releasing announcement of taking BP measurements.

### BP measurements {#s2-3-2}

Choose a regular calibration of the mercury sphygmomanometer or validated electronic sphygmomanometer. Use the standard specification cuff with air bag, which is 22 cm in length and 12 cm in width. Obese individuals or individuals with large arm circumferences used a large sized balloon cuff, and the upper arm was wrapped up at least 80% by the air bag. Each participant was asked to take a rest at least for 5 min; any vigorous activity was avoided; cigarettes and beverages containing caffeine, such as tea and coffee, were forbidden within 30 min; and the participants were instructed to empty their bladder before the BP measurement. BP was measured in a sitting position; the right upper arm should be exposed and the cuff should be kept at the same level as the heart. Each participant was measured three times with an interval time of 1 min, and the average of the last two readings was used for analysis.

Definitions {#s2-4}
-----------

Hypertension was defined as an SBP of ≥140 mm Hg or a DBP of ≥90 mm Hg, and/or a self-report of having an existing diagnosis of hypertension in accordance with the 2010 Chinese guideline. The new classification designates SBP≥130 mm Hg or DBP≥80 mm Hg and/or self-report of having an existing diagnosis of hypertension as hypertension according to the 2017 ACC/AHA guideline.

The ratio of hypertension to the total population was the prevalence of hypertension. Awareness of hypertension was defined as any self-reported previous diagnosis of hypertension by a healthcare professional physician; treatment was self-reported use of a prescription medication for hypertension management within the 2 weeks at the time of the interview; control referred to pharmacological treatment of hypertension associated with SBP\<140 mm Hg and DBP\<90 mm Hg during the past 2 weeks.

In addition, the study also estimated the prevalence (SBP≥130 mm Hg or DBP≥80 mm Hg) and control rate (SBP\<130 mm Hg and DBP \<80 mm Hg) of hypertension according to the 2017 ACC/AHA guideline.

Response rate was defined as the number of nurses responding to the questionnaire online divided by the total number of registered nurses in Hebei Province.

Statistical analysis {#s2-5}
--------------------

All variables were statistically described, the normality of the continuous variables was assessed, variables with a normal distribution were presented as mean±SD, variables with a skewed distribution were reported with medians and IQRs, and categorical data were presented by the percentage description. The prevalence of hypertension, as well as awareness, treatment and control rates of hypertension among hypertensive participants, was calculated according to the two guidelines. In addition, we reported the prevalence for each of the background characteristics of the study. Then we calculated the distribution of the population across five groups, including those who did not have an existing diagnosis of hypertension with SBP/DBP\<120/\<80 mm Hg, 120--129/\<80 mm Hg, 130--139/80--89 mm Hg and ≥140/90 mm Hg, and those who had an existing diagnosis of hypertension. To investigate the factors associated with newly diagnosed hypertension, the possible risk factors (gender, age, body mass index (BMI), years of hyperlipidaemia, years of diabetes, smoking, alcohol drinking and family history of hypertension) were incorporated into a multiple logistic regression analysis. Analyses were performed by using SPSS V.21.0 software. A two-sided p value of \<0.05 was considered statistically significant.

Results {#s3}
=======

Demographic characteristics {#s3-1}
---------------------------

A total of 93 603 participants from 512 medical institutions in 13 cities were enrolled in this study, accounting for 65.11% of the total number of registered nurses in Hebei Province. The main reason for non-response might be that some invited nurses had retired but had not logged out of the registration system; being on leave, including maternity leave, study leave and other reasons during the period of data collection; or refusing to participate.

After excluding 788 individuals with incomplete questionnaires, information in the 92 815 participants was included in the final analysis, among which consisted of 3677 men (3.96%) and 89 138 women (96.04%). The median age of participants was 30 (IQR 26--35) years (age range: 18--65 years). Our sample contained more people aged 35 years and younger (76.59%, [table 1](#T1){ref-type="table"}). Hypertension levels in different groups are shown in [table 1](#T1){ref-type="table"}. With increases in BMI, years of diabetes and years of hyperlipidaemia, the BP presented an increasing trend.

###### 

Characteristics of study participants (N=92 815）

  ---------------------------------------------------------------------------------------------
  Variable                         N        Percentage\   SBP\                   DBP\
                                            (%)           Median (IQR)/mean±SD   Median (IQR)
  -------------------------------- -------- ------------- ---------------------- --------------
  Overall                          92 815   100           110 (102--120)         70 (64--80)

  Gender                                                                         

   Female                          89 138   96.04         110 (101--120)         70 (63--80)

   Male                            3677     3.96          123 (120--130)         80 (75--85)

  Age (years)\*                                                                  

   18--25                          17 289   18.63         110 (102--120)         70 (63--78)

   26--35                          53 799   57.96         110 (100--120)         70 (62--78)

   36--45                          14 989   16.15         110 (105--120)         70 (65--80)

   46--55                          6376     6.87          120 (110--130)         80 (70--85)

   56--65                          250      0.27          130 (120--135)         80 (75--86)

   Missing data                    112      0.12          --                     --

  BMI (kg/m^2^)\*†                                                               

   Underweight                     7037     7.58          106 (99--110)          68 (60--70)

   Normal                          57 077   61.50         110 (100--120)         70 (61--77)

   Overweight                      22 235   23.96         118 (110--123)         72 (70--80)

   Obese                           6253     6.74          120 (110--130)         79 (70--80)

   Missing data                    213      0.23          --                     --

  Years of hyperlipidaemia\*                                                     

   0                               86 900   93.63         110 (101--120)         70 (63--80)

   \~5                             4837     5.21          120 (110--130)         80 (70--85)

   \~10                            636      0.69          125 (110--140)         80 (70--90)

   \>10                            127      0.14          128 (120--140)         82 (76--90)

   Missing data                    315      0.34          --                     --

  Years of diabetes\*                                                            

   0                               91 886   99.00         110 (102--120)         70 (64--80)

   \~5                             625      0.67          123 (110--138)         80 (70--90)

   \~10                            164      0.18          120 (110--130)         80 (70--90)

   \>10                            56       0.06          130±18                 80 (75--90)

   Missing data                    84       0.09          --                     --

  Smoking                                                                        

   Never                           91 020   98.07         110 (102-120)          70 (64-80)

   \<10 cigarettes/day             1280     1.38          110 (105--120)         70 (66--80)

   10--20 cigarettes/day           419      0.45          110 (105--120)         70 (68--80)

   \>20 cigarettes/day             96       0.10          110 (103--120)         70 (70--80)

  Alcohol drinking                                                               

   Never                           45 984   49.54         110 (102--120)         70 (64--80)

   Occasionally                    46 263   49.84         110 (102--120)         70 (64--80)

   Often                           568      0.61          110 (102--120)         70 (69--80)

  Family history of hypertension                                                 

   Yes                             44 451   47.89         110 (102--120)         70 (64--80)

   No                              48 364   52.11         110 (102--120)         70 (64--80)
  ---------------------------------------------------------------------------------------------

\*With the missing data.

†BMI was used to classify participants into categories of underweight (\<18.5), normal weight (18.5 to \<24), overweight (24 to \<28) and obese (≥28).

BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure.

### Prevalence, awareness, treatment and control rate of hypertension in Chinese nurses according to the two editions of the guidelines {#s3-1-1}

According to the 2017 ACC/AHA guideline, the prevalence of hypertension increased from 6.81% to 28.96%, and the prevalence rate was 3.25 times higher than that defined in the 2010 Chinese guideline. The awareness rate, drug treatment rate and control rate of hypertension according to the two guidelines are shown in [table 2](#T2){ref-type="table"}.

###### 

Prevalence, awareness, treatment and control rate of hypertension

  ---------------------------------------------------------------------------------------------------------------------------------------------------------
  Participants   Diagnostic criteria for hypertension   Prevalence (95% CI)      Awareness (95% CI)       Treatment (95% CI)       Control (95% CI)
  -------------- -------------------------------------- ------------------------ ------------------------ ------------------------ ------------------------
  Overall\       ≥140/90\*                              6.81 (6.65 to 6.97)      57.37 (57.05 to 57.69)   45.30 (44.98 to 45.62)   14.97 (14.74 to 15.20)
  (N=92 815)                                                                                                                       

  ≥130/80†       28.96 (28.67 to 29.25)                 13.50 (13.28 to 13.72)   10.73 (10.53 to 10.93)   0.81 (0.75 to 0.87)      

  Female\        ≥140/90\*                              6.28 (6.12 to 6.44)      58.52 (58.20 to 58.84)   46.74 (46.41 to 47.07)   16.10 (15.86 to 16.34)
  (n=89 138)                                                                                                                       

  ≥130/80†       27.41 (27.12 to 27.70)                 13.40 (13.18 to 13.62)   10.77 (10.57 to 10.97)   0.87 (0.81 to 0.93)      

  Male\          ≥140/90\*                              19.83 (18.54 to 21.12)   48.56 (46.94 to 50.18)   34.29 (32.76 to 35.82)   6.31 (5.52 to 7.10)
  (n=3677)                                                                                                                         

  ≥130/80†       66.41 (64.88 to 67.94)                 14.50 (13.36 to 15.64)   10.28 (9.30 to 11.26)    0.25 (0.09 to 0.41)      
  ---------------------------------------------------------------------------------------------------------------------------------------------------------

\*According to the diagnostic criteria for hypertension in the 2010 Chinese guideline.

†According to the diagnostic criteria for hypertension in the 2017 edition of the guideline.

### Multidimensional comparative analysis of hypertension prevalence among nursing staff {#s3-1-2}

According to the 2017 ACC/AHA guideline, the number of people with high BP in nursing staff rose from 6324 to 26 875, with a total increase of 20 551. The times of increase of hypertension prevalence in different groups according to the new guideline are shown in [table 3](#T3){ref-type="table"}.

###### 

Comparison of hypertension prevalence among nursing staff

  Variable                         N        ≥140/90\*   ≥130/80†                 Times of increase                            
  -------------------------------- -------- ----------- ------------------------ ------------------- ------------------------ ------
  Gender                                                                                                                      
   Female                          89 138   5595        6.28 (6.12 to 6.44)      24 433              27.41 (27.12 to 27.70)   3.36
   Male                            3677     729         19.83 (18.54 to 21.12)   2442                66.41 (64.88 to 67.94)   2.35
  Age (years)‡                                                                                                                
   18--25                          17 289   448         2.59 (2.35 to 2.83)      4303                24.89 (24.25 to 25.53)   8.61
   26--35                          53 799   2263        4.21 (4.04 to 4.38)      13 532              25.15 (24.78 to 25.52)   4.97
   36--45                          14 989   1784        11.90 (11.38 to 12.42)   5284                35.25 (34.49 to 36.01)   1.96
   46--55                          6376     1726        27.07 (25.98 to 28.16)   3524                55.27 (54.05 to 56.49)   1.04
   56--65                          250      91          36.40 (30.44 to 42.36)   185                 74.00 (68.56 to 79.44)   1.03
  BMI (kg/m^2^)§‡                                                                                                             
   Underweight                     7037     153         2.17 (1.83 to 2.51)      1028                14.61 (13.78 to 15.44)   5.73
   Normal                          57 077   2501        4.38 (4.21 to 4.55)      13 552              23.74 (23.39 to 24.09)   4.42
   Overweight                      22 235   2527        11.36 (10.94 to 11.78)   8941                40.21 (39.57 to 40.85)   2.54
   Obese                           6253     1120        17.91 (16.96 to 18.86)   3280                52.45 (51.21 to 53.69)   1.93
  Years of hyperlipidaemia‡                                                                                                   
   0                               86 900   4473        5.15 (5.00 to 5.30)      23 495              27.04 (26.74 to 27.34)   4.25
   \~5                             4837     1431        29.58 (28.29 to 30.87)   2712                56.07 (54.67 to 57.47)   0.90
   \~10                            636      292         45.91 (42.04 to 49.78)   417                 65.57 (61.88 to 69.26)   0.43
   \>10                            127      61          48.03 (39.34 to 56.72)   95                  74.80 (67.25 to 82.35)   0.56
  Years of diabetes‡                                                                                                          
   0                               91 886   5951        6.48 (6.32 to 6.64)      26 285              28.61 (28.32 to 28.90)   3.42
   \~5                             625      270         43.20 (39.32 to 47.08)   413                 66.08 (62.37 to 69.79)   0.53
   \~10                            164      64          39.02 (31.55 to 46.49)   99                  60.37 (52.88 to 67.86)   0.55
   \>10                            56       30          53.57 (40.51 to 66.63)   45                  80.36 (69.95 to 90.77)   0.50
  Smoking                                                                                                                     
  Never                            91 020   6200        6.81 (6.65 to 6.97)      26 290              28.88 (28.59 to 29.17)   3.24
   \<10 cigarettes/day             1280     87          6.80 (5.42 to 8.18)      415                 32.42 (29.86 to 34.98)   3.77
   10--20 cigarettes/day           419      32          7.64 (5.10 to 10.18)     139                 33.17 (28.66 to 37.68)   3.34
   \>20 cigarettes/day             96       5           5.21 (0.76 to 9.66)      31                  32.29 (22.94 to 41.64)   5.20
  Alcohol drinking                                                                                                            
   Never                           45 984   3085        6.71 (6.48 to 6.94)      13 226              28.76 (28.35 to 29.17)   3.29
   Occasionally                    46 263   3194        6.90 (6.67 to 7.13)      13 463              29.10 (28.69 to 29.51)   3.22
   Often                           568      45          7.92 (5.70 to 10.14)     186                 32.75 (28.89 to 36.61)   3.14
  Family history of hypertension                                                                                              
   Yes                             44 451   2967        6.67 (6.44 to 6.90)      12 743              28.67 (28.25 to 29.09)   3.30
   No                              48 364   3357        6.94 (6.71 to 7.17)      14 132              29.22 (28.81 to 29.63)   3.21

\*According to the diagnostic criteria for hypertension in 2010 Chinese guideline.

†According to the diagnostic criteria for hypertension in the 2017 edition of the guideline.

‡With the missing data.

§Body mass index was classified into underweight (\<18.5), normal weight (18.5 to \<24), overweight (24 to \<28) and obese (≥28).

[Table 4](#T4){ref-type="table"} shows that 60.68%, 10.36%, 22.14% and 2.90% of nurses not having an existing diagnosis of hypertension had SBP/DBP levels of \<120/80 mm Hg, 120--129/\<80 mm Hg, 130--139/80--89 mm Hg and ≥140/90 mm Hg, respectively. Additionally, 3.91% of the nurses had an existing diagnosis of hypertension. Among the nurses who did not have an existing diagnosis of hypertension, nurses with higher BP were older and were more likely to be men, overweight or obese, and tended to have hyperlipidaemia for less than 10 years or diabetes for less than 5 years.

###### 

Characteristics of study participants by blood pressure levels (N=92 815）

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Variable                           Nurses not having an existing diagnosis of hypertension   Nurses having an existing diagnosis of hypertension, n (%)\                                      
                                                                                               (n=3628)                                                                                         
  ---------------------------------- --------------------------------------------------------- ------------------------------------------------------------- ----------------- ---------------- ----------------
  Percentage of study participants   60.68 (60.28--61.08）                                     10.36\                                                        22.14\            2.90\            3.91\
                                                                                               (9.75--10.97）                                                (21.57--22.71）   (2.27--3.53）    (3.28--4.54）

  Gender                                                                                                                                                                                         

   Female                            55 669 (98.84)                                            9036 (93.93)                                                  18 838 (91.66)    2321 (86.09)     3274 (90.24)

   Male                              651 (1.16)                                                584 (6.07)                                                    1713 (8.34)       375 (13.91)      354 (9.76)

   Age (years)\*                     29 (26--34)                                               30 (27--35)                                                   30 (26--36)       31 (27--40)      43 (35--49)

  BMI\*†                                                                                                                                                                                         

   Underweight                       5587 (9.92)                                               422 (4.39)                                                    875 (4.26)        109 (4.04)       44 (1.21)

   Normal                            38 076 (67.61)                                            5449 (56.64)                                                  11 051 (53.77)    1220 (45.25)     1281 (35.31)

   Overweight                        10 363 (18.40)                                            2931 (30.47)                                                  6414 (31.21)      926 (34.35)      1601 (44.13)

   Obese                             2176 (3.86)                                               797 (8.28)                                                    2160 (10.51)      428 (15.88)      692 (19.07)

   Missing data                      118 (0.21)                                                21 (0.22)                                                     51 (0.25)         13 (0.48)        10 (0.28)

  Years of hyperlipidaemia\*                                                                                                                                                                     

   0                                 54 352 (96.51)                                            9053 (94.11)                                                  19 022 (92.56)    2373 (88.02)     2100 (57.88)

   \~5                               1652 (2.93)                                               473 (4.92)                                                    1281 (6.23)       251 (9.31)       1180 (32.52)

   \~10                              167 (0.30)                                                52 (0.54)                                                     125 (0.61)        39 (1.45)        253 (6.97)

   \>10                              26 (0.05)                                                 6 (0.06)                                                      34 (0.17)         1 (0.04)         60 (1.65)

   Missing data                      123 (0.22)                                                36 (0.37)                                                     89 (0.43)         32 (1.19)        35 (0.96)

  Years of diabetes\*                                                                                                                                                                            

   0                                 56 053 (99.53)                                            9548 (99.25)                                                  20 334 (98.94)    2649 (98.26)     3302 (91.01)

   \~5                               167 (0.30)                                                45 (0.47)                                                     143 (0.70）       31 (1.15)        239 (6.59)

   \~10                              47 (0.08)                                                 18 (0.19)                                                     35 (0.17)         10 (0.37)        54 (1.49)

   \>10                              10 (0.02)                                                 1 (0.01)                                                      15 (0.07)         1 (0.04)         29 (0.80)

   Missing data                      43 (0.08)                                                 8 (0.08)                                                      24 (0.12)         5 (0.19)         4 (0.11)

  Smoking                                                                                                                                                                                        

   Never                             55 276 (98.15)                                            9454 (98.27)                                                  20 090 (97.76)    2644 (98.07)     3556 (98.02)

   \<10 cigarettes/day               740 (1.31)                                                125 (1.30)                                                    328 (1.60)        37 (1.37)        50 (1.38)

   10--20 cigarettes/day             251 (0.45)                                                29 (0.30)                                                     107 (0.52)        12 (0.45)        20 (0.55)

   \>20 cigarettes/day               53 (0.09)                                                 12 (0.12)                                                     26 (0.13)         3 (0.11)         2 (0.06)

  Alcohol drinking                                                                                                                                                                               

   Never                             27 936 (49.60)                                            4822 (50.12)                                                  10 141 (49.35)    1280 (47.48)     1805 (49.75)

   Occasionally                      28 056 (49.82)                                            4744 (49.31)                                                  10 269 (49.97)    1402 (52.00)     1792 (49.39)

   Often                             328 (0.58)                                                54 (0.56)                                                     141 (0.69)        14 (0.52)        31 (0.85)

  Family history of hypertension                                                                                                                                                                 

   Yes                               27 017 (47.97)                                            4691 (48.76)                                                  9776 (47.57)      1259 (46.70)     1708 (47.08)

   No                                29 303 (52.03)                                            4929 (51.24)                                                  10 775 (52.43)    1437 (53.30)     1920 (52.92)

   SBP median (IQR) (mm Hg)          108 (100--110)                                            120 (120--123)                                                120 (120--125)    130 (120--140)   140 (130--145)

   DBP median (IQR) (mm Hg)          68 (60--70)                                               70 (70--75)                                                   80 (80--80)       90 (90--90)      90 (85--95)
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Participants were grouped into the higher category of SBP and DBP. For example, if a person had an SBP of 142 mm Hg and a DBP of 88 mm Hg, she/he was grouped into the ≥140/90 mm Hg category.

\*With the missing data.

†BMI was used to classify participants into categories of underweight (\<18.5), normal weight (18.5 to \<24), overweight (24 to \<28) and obese (≥28).

BMI, body mass index; DBP, diastolic blood pressure; SBP, systolic blood pressure.

[Table 5](#T5){ref-type="table"} shows that gender (OR 0.647, 95% CI 0.585 to 0.716, p\<0.001), age (OR 0.538, 95% CI 0.520 to 0.557, p\<0.001), BMI (OR 0.760, 95% CI 0.729 to 0.791, p\<0.001), years of hyperlipidaemia (OR 0.426, 95% CI 0.397 to 0.458, p\<0.001) and years of diabetes (OR 0.597, 95% CI 0.517 to 0.690, p\<0.001) were factors significantly associated with newly diagnosed hypertension. Women were more likely to be newly diagnosed with hypertension than men according to the 2017 ACC/AHA guideline. Besides, participants with no hyperlipidaemia, no diabetes, with lower age and with lower BMI value were more likely to be newly diagnosed with hypertension.

###### 

Multiple logistic regression of factors associated with newly diagnosed hypertension

  Variables                        OR      95% CI           P value
  -------------------------------- ------- ---------------- ---------
  Gender                           0.647   0.585 to 0.716   \<0.001
   Age (years)                     0.538   0.520 to 0.557   \<0.001
   BMI (kg/m^2^)                   0.760   0.729 to 0.791   \<0.001
  Years of hyperlipidaemia         0.426   0.397 to 0.458   \<0.001
  Years of diabetes                0.597   0.517 to 0.690   \<0.001
  Smoking                          1.070   0.921 to 1.243   0.379
  Alcohol drinking                 0.962   0.906 to 1.022   0.210
  Family history of hypertension   0.946   0.890 to 1.006   0.077

BMI, body mass index.

Discussion {#s4}
==========

At present, there were few studies on the current status of hypertension among nurses. This study was a cross-sectional survey based on a large sample of nursing staff. The final analysis included 92 815 participants from 512 medical institutions in 13 cities in Hebei Province. According to the 2010 Chinese guideline, the prevalence rate of hypertension was 6.81% in this study. Li *et al* ^[@R20]^ investigated 4032 cardiovascular physicians from 386 hospitals in China and found that the prevalence of hypertension among them was 13.1%. Liu *et al* [@R21] analysed the prevalence of hypertension among 1369 medical staff in a tertiary academic hospital in Zhengzhou, and the prevalence of hypertension was 18.33%. The prevalence of hypertension in this survey was lower than the above results, which may be related to the lower age and the greater proportion of women in the nursing staff. The report of China Health and Family Planning Commission indicated that the awareness rate of hypertension among people over 18 years old in China was 46.5%, the drug treatment rate was 41.1%, and the control rate was 13.8% in 2012.[@R22] In addition, a survey[@R23] of 174 621 people aged 18 years or older in 31 provinces in China from 2013 to 2014 showed that the awareness, treatment and control rate were 31.9%, 26.4% and 9.7%, respectively. Lu *et al* ^[@R24]^ organised a population-based screening hypertension project enrolling around 1.7 million adults aged 35--75 years from all 31 provinces in Mainland China. The rates of hypertension prevalence, awareness, treatment and control were 37.2%, 36.0%, 22.9% and 5.7%, respectively. In this survey, the awareness rate of hypertension in nursing staff was 57.37%, the rate of treatment was 45.30%, and the control rate was 14.97%, which were all higher than the above results. However, the control rate of hypertension among female nurses was 16.10%, and that among male nursing staff was only 6.31%. For medical workers, the awareness rate and the drug treatment rate of hypertension should have been higher. There is still a large space for improvement in the awareness rate of hypertension.

In this study, we sought to assess the potential impact of the new hypertension guideline on the status of BP in clinical nurses. According to the 2017 ACC/AHA guideline, the hypertension prevalence rate of nursing personnel in the survey increased to 28.96%, which increased 4.15 times among nurses aged under 45 years and 1.04 times among nurses aged 45 years or older. The prevalence rate of the population with no hyperlipidaemia, no diabetes, with lower age and with lower BMI value increased, suggesting that a more low-risk population would be diagnosed with hypertension. Meanwhile, the awareness rate, drug treatment rate and control rate of hypertension among Chinese nurses decreased from 57.37%, 45.30% and 14.97% to 13.50%, 10.73% and 0.81%, respectively.

A study from South Korea showed that the prevalence of hypertension was 49.2% based on the 2017 ACC/AHA guideline, while the number was 30.4% based on the previous guideline; the control rate decreased from 59.5% to 16.1%.[@R25] Additionally, a study from Nepal found that if the ACC/AHA guideline was applied, the overall prevalence of hypertension in Nepal would be approximately double (from 21.2% to 44.2%).[@R26] According to the standards of the new guideline, the prevalence rate of hypertension among nurses in China was lower than that of the above two studies, which might be related to the fact that most of the nurses were female, were lower in age level, and had more medical knowledge and resources. In addition, the difference could be due to several factors, including Nepal's predominantly rural population and low income. However, it is worth noting that the hypertension control rate among nurses according to the new standard is very low, only 0.81%. It had been reported that treatment of hypertension could reduce the risk of stroke and myocardial infarction by 30%--43% and 15%, respectively, along with reducing the risk of a number of other chronic conditions.[@R27] Consequently, the nursing staff should pay more attention to the management of BP. Improving lifestyle and monitoring the BP regularly were suggested to control the BP in a reasonable range.

According to the 2017 ACC/AHA guideline, for patients with clinical cardiovascular disease (CVD), antihypertensive medications should be used if the average SBP is ≥130 mm Hg or the average DBP is ≥80 mm Hg. For adults without CVD who have a 10-year predictive risk factor for atherosclerotic CVD of ≥10%, antihypertensive medications should be used if the average SBP is ≥130 mm Hg or the average DBP is ≥80 mm Hg.[@R7] Despite the fact that the number of nursing staff who need the medication treatment is speculated to increase according to the new guideline, they should take both their own conditions and medical history into consideration to make a reasonable judgement on whether it is necessary and proper for them to take the medicine.

Meanwhile, the ACC/AHA guideline would require expansion of the necessary public health infrastructure to manage the substantial increase in the public health burden of hypertension in China. Different countries have different epidemiological characteristics, genetic background, disease control and economic levels. More facts founded on evidence-based medicine are needed to confirm whether the new guideline is applicable to China, how to determine the boundary value of hypertension and whether lowering the hypertension diagnosis standard to 130/80 mm Hg can improve the prognosis. The number of patients with hypertension in China is huge, and the medical resources are relatively insufficient. The report of the Chinese Center for Disease Control and Prevention in 2013 pointed out that the number of hypertension in China had risen to 330 million in 2010, and the direct economic burden caused by hypertension reached 210.3 billion yuan in 2013, accounting for 6.61% of the total health cost in China. The number of people with high BP in China will rise by a large margin according to the new guidelines, which poses more severe challenges to medical and health resources.

Limitations {#s5}
===========

Some limitations should be considered when interpreting our data. First of all, this survey used the average BP measured two times on the same day, which might have led to false-positive diagnoses, resulting in overestimation of the prevalence rate. Second, the BP was measured by nurses themselves rather than the staff trained unifiedly, but all nurses had received professional knowledge of BP measurement. In addition, a unified description of the measurement methods and matters of attention were carried out in the study, which could ensure the reliability of the measurement results. Third, the different BP measuring instruments used might have had some effect on the data, but the sphygmomanometer had been tested and corrected. The BP measurement in the survey was carried out according to international measurement and quality control regulations, which could guarantee the reliability of the measurement results. Furthermore, the small proportion of men and nurses over 55 years old in this study might have had some influence on the study results. Finally, the generalisability of our results might have been restricted because the participants being recruited were from only one province in China. Future studies should be carried out to recruit participants from other cities in China.
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